Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
40.4M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
25.9M
-
Shares change
-
+4.25M
-
Total reported value, excl. options
-
$1.14B
-
Value change
-
+$184M
-
Number of buys
-
81
-
Number of sells
-
-51
-
Price
-
$44.12
Significant Holders of Pulmonx Corp - COMMON STOCK (LUNG) as of Q2 2021
146 filings reported holding LUNG - Pulmonx Corp - COMMON STOCK as of Q2 2021.
Pulmonx Corp - COMMON STOCK (LUNG) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.9M shares
of 40.4M outstanding shares and own 64.04% of the company stock.
Largest 10 shareholders include Capital World Investors (2.55M shares), BlackRock Inc. (2.32M shares), PRIMECAP MANAGEMENT CO/CA/ (1.96M shares), VANGUARD GROUP INC (1.89M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.8M shares), RTW INVESTMENTS, LP (1.13M shares), Champlain Investment Partners, LLC (1.07M shares), GILDER GAGNON HOWE & CO LLC (1.05M shares), KPCB XIII Associates, LLC (995K shares), and Point72 Asset Management, L.P. (661K shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.